Three-dimensional (3D) cell culture techniques represent a transformative advancement in biomedical research, particularly in drug discovery and development. By more closely replicating the physiological and microenvironmental conditions of in vivo tissues, 3D cell cultures enable more accurate assessments of drug efficacy, toxicity, and therapeutic potential compared to traditional two-dimensional (2D) cultures. These systems not only provide a more realistic model for preclinical testing but also allow for the study of complex cell-cell and cell-matrix interactions, which are often overlooked in 2D systems. This review provides a comprehensive examination of studies utilizing spheroids and organoids in 3D culture systems for drug screening and development. Furthermore, it highlights the critical role of these models in uncovering novel therapeutic targets, understanding disease mechanisms, and optimizing drug delivery strategies. Key challenges, such as scalability, standardization, and integration with high-throughput screening platforms, are also discussed. In conclusion, 3D cell culture techniques hold immense promise for revolutionizing the drug discovery pipeline, offering a more predictive and ethical approach to preclinical research while bridging the gap between laboratory findings and clinical outcomes.
Three-dimensional (3D) cell culture techniques represent a transformative advancement in biomedical research, particularly in drug discovery and development. By more closely replicating the physiological and microenvironmental conditions of in vivo tissues, 3D cell cultures enable more accurate assessments of drug efficacy, toxicity, and therapeutic potential compared to traditional two-dimensional (2D) cultures. These systems not only provide a more realistic model for preclinical testing but also allow for the study of complex cell-cell and cell-matrix interactions, which are often overlooked in 2D systems. This review provides a comprehensive examination of studies utilizing spheroids and organoids in 3D culture systems for drug screening and development. Furthermore, it highlights the critical role of these models in uncovering novel therapeutic targets, understanding disease mechanisms, and optimizing drug delivery strategies. Key challenges, such as scalability, standardization, and integration with high-throughput screening platforms, are also discussed. In conclusion, 3D cell culture techniques hold immense promise for revolutionizing the drug discovery pipeline, offering a more predictive and ethical approach to preclinical research while bridging the gap between laboratory findings and clinical outcomes.
Primary Language | English |
---|---|
Subjects | Synthetic Biology, Structural Biology, Tissue Engineering |
Journal Section | Review |
Authors | |
Publication Date | December 30, 2024 |
Submission Date | May 23, 2024 |
Acceptance Date | December 19, 2024 |
Published in Issue | Year 2024 |
Frontiers in Life Sciences and Related Technologies is licensed under a Creative Commons Attribution 4.0 International License.